ArticleAmerican journal of translational research2023
Prognosis of a Chinese patient with chronic lymphocytic leukemia who acquired a TP53 mutation following treatment with a BTK inhibitor.
Yan-Ling Ding et al.PubMed ↗Full text ↗
No numbers read from the abstract.